GALE, EDWY & Extended Watchlist


Galena Biopharma, Inc. GALE

We were happy to see that GALE earned us a spot on Penny Stock Rumble’s Top Gainers List this week. From its low (Wed.) of 1.6525 to yesterday’s high of 2.10, we saw total possible gains of 27% The stock had news out, and closed strong on the day at 2.04 on around 3X the average volume.

The GALE Chart is exhibiting all the telltale signs of a momentum mover, and we’re glad we were watching closely enough to hitch a ride! As you can see below, the RSI is screaming toward the power zone, while the Slow STO and the PPO have just crossed and are swinging sharply to the North.

Yesterday’s News:

LAKE OSWEGO, Ore., Nov 29, 2012 (GlobeNewswire via COMTEX) — Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced two presentations at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The event will be held December 4-8, 2012 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.


eDoorways International Corp. EDWY

EDWY first appeared on our extended watchlist this week. The stock recently ran from a low of .005 to a high of a nickel (+810%) between Sept 18 and Nov 1st. Following that big run, the stock consolidated to find support off of a penny-and-a-half.

Yesterday we observed trades as low as .0153, and as high as .025, for total possible gains of over 60% on the day. We are looking at key levels of resistance at .026 (20DMA) and .031 (200DMA), and judging by the history of the stock, a push past those levels could really lead to a serious breakout.

Indicators on the chart all seem to be shaping up rather nicely. We notice that the Accum/Dist has been steadily rising, the RSI is just on the cusp of breaking the 50DMA, and the PPO is currently pinching, hinting at a bullish cross. The bars on the histogram are also about to flip up to the bullish side, and we had a recent cross on the Slow STO.


Extended Watchlist: